Source: FinanzNachrichten

Salix Pharmaceuticals: Salix Pharmaceuticals: Salix Will Present Rifaximin Data at AASLD's The Liver Meeting 2022

LAVAL, QC / ACCESSWIRE / November 4, 2022 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health") and its gastroenterology business, Salix Pharmaceuticals ("Salix"), today announced on...

Read full article »
Est. Annual Revenue
$1.0-5.0B
Agree?
Est. Employees
500-1.0K
Agree?
Robert Spurr's photo - President of Salix Pharmaceuticals

President

Robert Spurr

CEO Approval Rating

82/100

Read more